These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 174310)

  • 41. Effect of estradiol and prolactin on galactosyltransferase and alpha-lactalbumin activities in rat mammary gland and mammary tumor.
    Ip C; Dao TL
    Cancer Res; 1978 Jul; 38(7):2077-83. PubMed ID: 418872
    [No Abstract]   [Full Text] [Related]  

  • 42. Oestrogen-binding and the hormone respinsiveness of tumours.
    King RJ; Smith JA; Steggles AW
    Steroidologia; 1970; 1(2):73-88. PubMed ID: 4938760
    [No Abstract]   [Full Text] [Related]  

  • 43. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
    Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
    Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
    [No Abstract]   [Full Text] [Related]  

  • 44. Prolactin and estrogen receptors in breast cancer.
    McGuire WL; Chamness GC; Horwitz KB; Zava DT
    Pathobiol Annu; 1977; 7():191-211. PubMed ID: 201904
    [No Abstract]   [Full Text] [Related]  

  • 45. Endocrinology in cancer of the breast. Status and prospects.
    Brennan MJ
    Am J Clin Pathol; 1975 Dec; 64(6):797-809. PubMed ID: 173180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin and murine mammary tumorigenesis: a review.
    Welsch CW; Nagasawa H
    Cancer Res; 1977 Apr; 37(4):951-63. PubMed ID: 191183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternate fluctuations of leucine and thymidine incorporation by mammary tumors in rats during the estrous cycle.
    Lee C; Murphy JJ; Diamond CA; Rafferty NS; Oyasu R
    Cancer Res; 1977 Sep; 37(9):3301-5. PubMed ID: 406988
    [No Abstract]   [Full Text] [Related]  

  • 49. Specific estrogen binding in vivo in the R3230AC mammary adenocarcinoma of the rat.
    Boylan ES; Wittliff JL
    Cancer Res; 1973 Nov; 33(11):2903-8. PubMed ID: 4355983
    [No Abstract]   [Full Text] [Related]  

  • 50. Progesterone and breast cancer.
    Diamond EJ; Hollander VP
    Mt Sinai J Med; 1979; 46(2):225-35. PubMed ID: 108535
    [No Abstract]   [Full Text] [Related]  

  • 51. Specific estrogen receptor and its relation to response to oophorectomy in rat mammary cancer induced by 7,12-dimethylbenz[a]anthracene.
    Nomura Y; Abe Y; Inokuchi K
    Gan; 1974 Dec; 65(6):523-8. PubMed ID: 4377255
    [No Abstract]   [Full Text] [Related]  

  • 52. Regression of "hormone-independent" DMBA-induced mammary carcinomas in response to GP 48989 and its effects on hormone receptors.
    Schmidt-Ruppin KH; Joss U; Schieweck K
    Oncology; 1976; 33(5-6):229-31. PubMed ID: 829153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of plasma estrogen sulfates in mammary cancer cells.
    Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
    Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
    [No Abstract]   [Full Text] [Related]  

  • 54. Hormone dependence in breast cancer.
    McGuire WL; Chamness GC; Costlow ME; Shepherd RE
    Metabolism; 1974 Jan; 23(1):75-100. PubMed ID: 4357247
    [No Abstract]   [Full Text] [Related]  

  • 55. [Receptors of--steroid hormones: Estrogens].
    Kato J
    Nihon Rinsho; 1974 Nov; 32(11):3275-81. PubMed ID: 4375209
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of relationship between prolactin binding and growth rate of carcinogen-induced mammary tumors or circulating levels of mammotropic hormones in rats.
    Nagasawa H; Yanai R; Shiota K; Nakajima Y
    Gan; 1980 Apr; 71(2):271-2. PubMed ID: 6259012
    [No Abstract]   [Full Text] [Related]  

  • 57. Quantitation of estrogen receptor in mammary carcinoma.
    McGuire WL
    Methods Enzymol; 1975; 36():248-54. PubMed ID: 162982
    [No Abstract]   [Full Text] [Related]  

  • 58. Adrenal dehydroepiandrosterone and human mammary cancer.
    Adams JB; Archibald L; Clarke C
    Cancer Res; 1978 Nov; 38(11 Pt 2):4036-40. PubMed ID: 151584
    [No Abstract]   [Full Text] [Related]  

  • 59. Estrogen-binding in vitro by DMBA-induced rat mammary tumors: its relationship to hormone responsiveness.
    Mobbs BG; Johnson IE
    Eur J Cancer (1965); 1974 Nov; 10(11):757-63. PubMed ID: 4219917
    [No Abstract]   [Full Text] [Related]  

  • 60. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.
    Kranzfelder G; Hartmann RW; von Angerer E; Schönenberger H; Bogden AE
    J Cancer Res Clin Oncol; 1982; 103(2):165-80. PubMed ID: 6284766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.